Diagnostic and prognostic problems with the Prader-Willi syndrome

Area of Science:

• Genetics
• Neurodevelopmental Disorders
• Molecular Diagnostics

Background:

• Prader-Willi syndrome (PWS) is a rare neurodevelopmental disorder.
• It stems from genetic alterations in the 15q11-q13 region, often paternal deletions or maternal disomy.
• Current diagnostic methods lack molecular subtyping capabilities.

Purpose of the Study:

• To highlight the limitations of current PWS diagnostic methods.
• To emphasize the need for improved molecular classification of PWS.
• To underscore the importance of accurate diagnosis for patient prognosis and treatment.

Main Methods:

• Review of current diagnostic standards for PWS.
• Analysis of the information provided by DNA methylation testing.
• Identification of gaps in molecular subtyping.

Main Results:

• DNA methylation analysis is the current gold standard for PWS diagnosis.
• This method does not differentiate between the molecular classes of PWS.
• Lack of molecular subtyping prevents accurate diagnostic and prognostic determination.

Conclusions:

• Further research is essential for developing advanced diagnostic tools for PWS.
• Standardized, accurate, and cost-effective testing is needed.
• Improved molecular diagnostics will facilitate better patient management and treatment strategies.